Literature DB >> 17332127

Comparison of the vastus-splitting and median parapatellar approaches for primary total knee arthroplasty: a prospective, randomized study. Surgical technique.

Matthew J Kelly1, Mustasim N Rumi, Milind Kothari, Michael A Parentis, Katrina J Bailey, William M Parrish, Vincent D Pellegrini.   

Abstract

BACKGROUND: A vastus-splitting approach for total knee arthroplasty has been advocated to preserve function of the extensor mechanism and to decrease the prevalence of lateral release. Critics have claimed that there is greater blood loss and compromised exposure in large patients who are managed with this approach. The purpose of the present study was to compare vastus-splitting and median parapatellar approaches for primary total knee arthroplasty.
METHODS: Forty-two consecutive patients (fifty-one knees) undergoing primary total knee arthroplasty were randomized to treatment with a median parapatellar or vastus-splitting approach. The interval of the vastus muscle split was marked with radiopaque vascular clips. Surgical data, functional parameters, and preoperative and postoperative electromyograms were assessed.
RESULTS: Early (six-month) and intermediateterm (five-year) follow-up showed no differences in functional parameters, tourniquet time, or the frequency of patellar resurfacing. Significantly more lateral releases (p < 0.01) and greater blood loss (p = 0.03) occurred in the median parapatellar group. Nine (43%) of twenty-one knees in the vastus-splitting group had abnormal electromyographic findings at six months postoperatively, whereas all patients in the median parapatellar group had normal findings. Seven knees with abnormal electromyographic findings at six months had normal findings when restudied at five years; in each of these knees, the vastus split had been developed bluntly. The other two knees with abnormal findings at six months had had sharp dissection for the muscle split. Both of these knees had chronic changes, one with changes indicative of reinnervation and the other with ongoing denervation, but neither demonstrated functional compromise.
CONCLUSIONS: The vastus-splitting approach offers a viable alternative to the median parapatellar approach for primary total knee arthroplasty that reduces the need for lateral retinacular release without impairment of quadriceps function. Electromyographic abnormalities in the quadriceps muscle have no functional consequence and most likely represent reversible neurapraxic injury that may be avoided by blunt dissection in the vastus medialis muscle.

Entities:  

Mesh:

Year:  2007        PMID: 17332127     DOI: 10.2106/JBJS.F.01190

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  [The mini-midvastus approach for total knee arthroplasty].

Authors:  Robert Hube; Manuel Keim; Hermann Otto Mayr
Journal:  Oper Orthop Traumatol       Date:  2009-03       Impact factor: 1.154

2.  Short-keeled cemented tibial components show an increased risk for aseptic loosening.

Authors:  Christian Ries; Markus Heinichen; Florian Dietrich; Eike Jakubowitz; Christian Sobau; Christian Heisel
Journal:  Clin Orthop Relat Res       Date:  2012-10-05       Impact factor: 4.176

3.  A comparison between subvastus and midvastus approaches for staged bilateral total knee arthroplasty:a prospective, randomised study.

Authors:  T Masjudin; Zh Kamari
Journal:  Malays Orthop J       Date:  2012-11

4.  Total knee arthroplasties performed with a mini-incision or a standard incision. Similar results at six months follow-up.

Authors:  Daniel Hernandez-Vaquero; Alfonso Noriega-Fernandez; Abelardo Suarez-Vazquez
Journal:  BMC Musculoskelet Disord       Date:  2010-02-06       Impact factor: 2.362

5.  Anterolateral approach with tibial tubercle osteotomy versus standard medial approach for primary total knee arthroplasty: does it matter?

Authors:  Michael T Hirschmann; Mathias Hoffmann; Robert Krause; Reza-Amir Jenabzadeh; Markus P Arnold; Niklaus F Friederich
Journal:  BMC Musculoskelet Disord       Date:  2010-07-22       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.